Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES:
Net income (loss)	$ 3,303	$ 2,117	$ 1,562
Adjustments to reconcile to net cash provided (used) by operating activities:
Depreciation and amortization	2,071	2,009	1,842
Provision (benefit) for deferred income taxes	951	431	509
Equity (earnings) losses	(589)	(637)	(608)
Distributions from equity-method investees (Note 8)	796	865	757
Net unrealized (gain) loss from commodity derivative instruments	(660)	249	109
Gain on sale of business (Note 3)	(129)	0	0
Inventory write-downs	30	161	15
Amortization of stock-based awards	77	73	81
Cash provided (used) by changes in current assets and liabilities:
Accounts receivable	1,089	(733)	(545)
Inventories	13	(110)	(139)
Other current assets and deferred charges	60	(33)	(63)
Accounts payable	(1,009)	410	643
Accrued and other current liabilities	(19)	209	58
Changes in current and noncurrent commodity derivative assets and liabilities	200	94	(277)
Other, including changes in noncurrent assets and liabilities	(246)	(216)	1
Net cash provided (used) by operating activities	5,938	4,889	3,945
FINANCING ACTIVITIES:
Proceeds from (payments of) commercial paper – net	372	345	0
Proceeds from long-term debt	2,755	1,755	2,155
Payments of long-term debt	(634)	(2,876)	(894)
Proceeds from issuance of common stock	6	54	9
Purchases of treasury stock	(130)	(9)	0
Common dividends paid	(2,179)	(2,071)	(1,992)
Dividends and distributions paid to noncontrolling interests	(213)	(204)	(187)
Contributions from noncontrolling Interests	18	18	9
Payments for debt issuance costs	(23)	(17)	(26)
Other – net	(21)	(37)	(16)
Net cash provided (used) by financing activities	(49)	(3,042)	(942)
INVESTING ACTIVITIES:
Capital expenditures (1)	(2,516)	(2,253)	(1,239)
Dispositions - net	(51)	(30)	(8)
Proceeds from sale of business (Note 3)	346	0	0
Purchases of businesses, net of cash acquired (Note 3)	(1,568)	(933)	(151)
Purchases of and contributions to equity-method investments (Note 8)	(141)	(166)	(115)
Other – net	39	7	48
Net cash provided (used) by investing activities	(3,891)	(3,375)	(1,465)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	1,998	(1,528)	1,538
Cash and cash equivalents at beginning of year	152	1,680	142
Cash and cash equivalents at end of year	2,150	152	1,680
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]
(1)  Increases to property, plant, and equipment	(2,564)	(2,394)	(1,305)
Changes in related accounts payable and accrued liabilities	48	141	66
Capital expenditures	$ (2,516)	$ (2,253)	$ (1,239)